V

VolitionRX Limited
D

VNRX

0.51540
USD
0.00
(0.08%)
مغلق
حجم التداول
6,311
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
53,097,888
أصول ذات صلة
AAPL
AAPL
-6.070
(-3.01%)
195.340 USD
AMZN
AMZN
-1.760
(-0.87%)
201.040 USD
GOOGL
GOOGL
-3.470
(-2.02%)
168.480 USD
MSFT
MSFT
-3.09
(-0.68%)
450.25 USD
NFLX
NFLX
-1.73
(-0.15%)
1,185.34 USD
NVDA
NVDA
-1.600
(-1.20%)
131.300 USD
PYPL
PYPL
-1.670
(-2.33%)
69.870 USD
TSLA
TSLA
-5.98
(-1.73%)
339.30 USD
V
V
-5.37
(-1.50%)
353.53 USD
المزيد
الأخبار المقالات

العنوان: VolitionRX Limited

القطاع: Healthcare
الصناعة: Medical Devices
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.